ctrl K

Price Alert

Prelude Therapeutics (PRLD)

NASDAQ: PRLD · Real-Time Price · USD

0.84

-0.10 (-11.11%)

At close: Aug 15, 2025, 3:59 PM

0.87

4.05%

After-hours: Aug 15, 2025, 04:54 PM EDT

Prelude Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	12.47M	25.29M	30.61M	31.83M
Short-Term Investments	121.14M	207.64M	171.12M	259.4M
Long-Term Investments	n/a	n/a	4.04M	4.04M
Other Long-Term Assets	4.15M	4.34M	5.38M	303K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	2.28M	2.65M	2.65M	3.88M
Total Current Assets	135.9M	235.59M	204.38M	295.12M
Property-Plant & Equipment	35.47M	37.74M	6.7M	5.64M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	39.62M	42.08M	16.12M	9.98M
Total Assets	175.51M	277.67M	220.5M	305.1M
Account Payables	7.73M	4.58M	6.78M	7.84M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	2.7M	n/a	1.83M	1.74M
Other Current Liabilities	9.79M	6.61M	5.58M	3.27M
Total Current Liabilities	25.64M	21.83M	21.7M	19.2M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	3.09M	3.34M	3.36M	n/a
Total Long-Term Liabilities	18.41M	18.75M	3.36M	n/a
Total Liabilities	44.06M	40.58M	25.06M	19.2M
Total Debt	18.02M	16.89M	1.83M	1.74M
Common Stock	4K	5K	5K	5K
Retained Earnings	-583.56M	-456.39M	-334.56M	-219.12M
Comprehensive Income	35K	223K	-1.69M	-711K
Shareholders Equity	131.46M	237.09M	195.44M	285.9M
Total Investments	121.14M	207.64M	171.12M	259.4M